Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3)

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3 SUPPL., 2008, Pages

  Aylward, Lesa L ^a   Barton, Hugh A ^b   Hays, Sean M ^a  

^a LLP   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

BEs; Biomonitoring; Biomonitoring Equivalents; Pharmacokinetics; Toluene

Indexed keywords

TOLUENE;

ARTICLE; BIOEQUIVALENCE; BIOLOGICAL MONITORING; BLOOD SAMPLING; CALCULATION; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); ENVIRONMENTAL PROTECTION; GENETIC POLYMORPHISM; HEALTH HAZARD; HUMAN; NONHUMAN; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; URINALYSIS; WORLD HEALTH ORGANIZATION;

ANIMALS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GUIDELINES AS TOPIC; HUMANS; MODELS, BIOLOGICAL; RISK ASSESSMENT; SOLVENTS; TOLUENE;

EID: 47749140699     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.05.009     Document Type: Article

References (41)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 2000. Toxicological profile for toluene. Available from: .
2. Al-Ghamdi S.S., Raftery M.J., and Yaqoob M.M. Acute solvent exposure induced activation of cytochrome P4502E1 causes proximal tubular cell necrosis by oxidative stress. Toxicol. In Vitro 17 (2003) 335-341
3. Al-Ghamdi S.S., Raftery M.J., and Yaqoob M.M. Organic solvent-induced proximal tubular cell toxicity via caspase-3 activation. J. Toxicol. Clin. Toxicol. 41 (2003) 941-945
4. American Conference of Governmental and Industrial Hygienists (ACGIH), 2001. Documentation of toluene BEI. Available from: .
5. Angerer J., Schildbach M., and Krämer A. S-p-Toluylmercapturic acid in the urine of workers exposed to toluene: a new biomarker for toluene exposure. Arch. Toxicol. 72 (1998) 119-123
6. Baelum J. Human solvent exposure. Factors influencing the pharmacokinetics and acute toxicity. Pharmacol. Toxicol. 68 Suppl. 1 (1991) 1-36
7. Baelum J., Molhave L., Honore Hansen S., and Dossing M. Hepatic metabolism of toluene after gastrointestinal uptake in humans. Scand. J. Work Environ. Health 19 (1993) 55-62
8. Benignus V.A., Boyes W.K., Kenyon E.M., and Bushnell P.J. Quantitative comparisons of the acute neurotoxicity of toluene in rats and humans. Toxicol. Sci. 100 (2007) 146-155
9. Bushnell P.J., Oshiro W.M., Samsam T.E., Benignus V.A., Krantz Q.T., and Kenyon E.M. A dosimetric analysis of the acute behavioral effects of inhaled toluene in rats. Toxicol. Sci. 99 (2007) 181-189
10. Churchill J.E., Ashley D.L., and Kaye W.E. Recent chemical exposures and blood volatile organic compound levels in a large population-based sample. Arch. Environ. Health 56 (2001) 157-166
11. Dossing M., Aelum J.B., Hansen S.H., Lundqvist G.R., and Andersen N.T. Urinary hippuric acid and orthocresol excretion in man during experimental exposure to toluene. Br. J. Ind. Med. 40 (1983) 470-473
12. Fustinoni S., Mercadante R., Campo L., Scibetta L., Valla C., Consonni D., and Foa V. Comparison between urinary o-cresol and toluene as biomarkers of toluene exposure. J. Occup. Environ. Hyg. 4 (2007) 1-9
13. Gemma S., Vichi S., and Testai E. Individual susceptibility and alcohol effects: biochemical and genetic aspects. Ann. Ist. Super. Sanita 42 (2006) 8-16
14. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., and Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 47 (2007) 96-109
15. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk P.J., Dizio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., and Yager J.W. Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 51 (2008) S4-S15
16. Health Canada, 1996. Health-based tolerable daily intakes/concentrations and tumorigenic doses/concentrations for priority substances. Environmental Health Directorate. Available from: .
17. Heuser V.D., Erdtmann B., Kvitko K., Rohr P., and da Silva J. Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility. Toxicology 232 (2007) 235-247
18. Inoue O., Kanno E., Kasai K., Ukai H., Okamoto S., and Ikeda M. Benzylmercapturic acid is superior to hippuric acid and o-cresol as a urinary marker of occupational exposure to toluene. Toxicol. Lett. 147 (2004) 177-186
19. International Agency for Research on Cancer (IARC), 1999. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 71: Re-Evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Summary of Data Reported and Evaluation. Available from: (accessed 12/2007).
20. Jang J.-Y. Simulation of the toluene in venous blood with a physiologically based pharmacokinetic model: its application to biological exposure index development. Appl. Occup. Environ. Hyg. 11 (1996) 1092-1095
21. Johnsrud E.K., Koukouritaki S.B., Divakaran K., Brunengraber L.L., Hines R.N., and McCarver D.G. Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 307 (2003) 402-437
22. Kawai T., Ukai H., Inoue O., Maejima Y., Fukui Y., Ohashi F., Okamoto S., Takada S., Sakurai H., and Ikeda M. Evaluation of biomarkers of occupational exposure to toluene at low levels. Int. Arch. Occup. Environ. Health 81 (2008) 253-262
23. Kezic S., Calkoen F., Wenker M.A., Jacobs J.J., and Verberk M.M. Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Toxicol. Ind. Health 22 (2006) 281-289
24. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstein D.A., Kilpatrick M.E., Krewski D., Bartels M., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., Yager J.W., and Hays S.M. Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 51 (2008) S16-S26
25. National Toxicology Program (NTP), 1990. Toxicology and carcinogenesis studies of toluene (CAS #108-88-3) in F344/N rats and B6C3F1 mice (inhalation studies). NTP Technical Report Series No. 371. U.S. Department of Health and Human Services.
26. Neubert D., Gericke C., Hanke B., Beckmann G., Baltes M.M., Kühl K.P., Bochert G., Hartmann J., and Toluene Field Study Group. Multicenter field trial on possible health effects of toluene: II. Cross-sectional evaluation of acute low-level exposure. Toxicology 168 (2001) 158-183
27. Nong A., McCarver D.G., Hines R.N., and Krishnan K. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. Toxicol. Appl. Pharmacol. 214 (2006) 78-87
28. Pelekis M., Gephart L.A., and Lerman S.E. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regul. Toxicol. Pharmacol. 33 (2001) 12-20
29. Pierce C.H., Dills R.L., Morgan M.S., Nothstein G.L., Shen D.D., and Kalman D.A. Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model. Toxicol. Appl. Pharmacol. 139 (1996) 49-61
30. Pierce C.H., Dills R.L., Morgan M.S., Vicini P., and Kalman D.A. Biological monitoring of controlled toluene exposure. Int. Arch. Occup. Environ. Health 71 (1998) 433-444
31. Sexton K., Adgate J.L., Church T.R., Ashley D.L., Needham L.L., Ramachandran G., Fredrickson A.L., and Ryan A.D. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ. Health Perspect. 113 (2005) 342-349
32. Stengel B., Cenee S., Limasset J.C., Diebold F., Michard D., Druet P., and Hemon D. Immunologic and renal markers among photogravure printers exposed to toluene. Scand. J. Work Environ. Health 24 (1998) 276-284
33. Sullivan M.J., and Conolly R.B. Comparison of blood toluene levels after inhalation and oral administration. Environ. Res. 45 (1988) 64-70
34. Tardif R., Lapare S., Krishnan K., and Brodeur J. Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat. Toxicol. Appl. Pharmacol. 120 (1993) 266-273
35. Tardif R., Droz P.O., Charest-Tardif G., Pierrehumbert G., and Truchon G. Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling. Toxicol. Lett. 134 (2002) 155-163
36. Tardif R., Lapare S., Charest-Tardif G., Brodeur J., and Krishnan K. Physiologically based modeling of a mixture of toluene and xylene in humans. Risk Anal. 15 (1995) 335-342
37. Truchon G., Tardif R., and Brodeur J. o-Cresol: a good indicator of exposure to low levels of toluene. Appl. Occup. Environ. Hyg. 14 (1999) 677-681
38. United States Environmental Protection Agency (USEPA), 2005. Toxicological Review of Toluene (CAS No. 108-88-3) In Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635/R-05/004.
39. van Asperen J., Rijcken W.R., and Lammers J.H. Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats. Toxicol. Lett. 138 (2003) 51-62
40. World Health Organization (WHO), 2004. Guidelines for Drinking-Water Quality, vol. 1. Recommendations, third ed. World Health Organization, Geneva.
41. World Health Organization (WHO), 2005. Air Quality Guidelines for Europe, second ed. WHO Regional Office for Europe Copenhagen. Available from: .